These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15358094)

  • 1. Metabolism of A-ring diastereomers of 1alpha,25-dihydroxyvitamin D3 by CYP24A1.
    Kusudo T; Sakaki T; Abe D; Fujishima T; Kittaka A; Takayama H; Hatakeyama S; Ohta M; Inouye K
    Biochem Biophys Res Commun; 2004 Sep; 321(4):774-82. PubMed ID: 15358094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel metabolism of 1 alpha,25-dihydroxyvitamin D3 with C24-C25 bond cleavage catalyzed by human CYP24A1.
    Sawada N; Kusudo T; Sakaki T; Hatakeyama S; Hanada M; Abe D; Kamao M; Okano T; Ohta M; Inouye K
    Biochemistry; 2004 Apr; 43(15):4530-7. PubMed ID: 15078099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of vitamin D3 by cytochromes P450.
    Sakaki T; Kagawa N; Yamamoto K; Inouye K
    Front Biosci; 2005 Jan; 10():119-34. PubMed ID: 15574355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
    Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
    Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-function analysis of vitamin D 24-hydroxylase (CYP24A1) by site-directed mutagenesis: amino acid residues responsible for species-based difference of CYP24A1 between humans and rats.
    Hamamoto H; Kusudo T; Urushino N; Masuno H; Yamamoto K; Yamada S; Kamakura M; Ohta M; Inouye K; Sakaki T
    Mol Pharmacol; 2006 Jul; 70(1):120-8. PubMed ID: 16617161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic stability of 3-epi-1α,25-dihydroxyvitamin D3 over 1 α 25-dihydroxyvitamin D3: metabolism and molecular docking studies using rat CYP24A1.
    Rhieu SY; Annalora AJ; Wang G; Flarakos CC; Gathungu RM; Vouros P; Sigüeiro R; Mouriño A; Schuster I; Palmore GT; Reddy GS
    J Cell Biochem; 2013 Oct; 114(10):2293-305. PubMed ID: 23606409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cytochrome P450-dependent differential metabolism among three 2α-substituted-1α,25-dihydroxyvitamin D(3) analogs.
    Yasuda K; Ikushiro S; Kamakura M; Takano M; Saito N; Kittaka A; Chen TC; Ohta M; Sakaki T
    J Steroid Biochem Mol Biol; 2013 Jan; 133():84-92. PubMed ID: 22982757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-25 hydroxylation of 1alpha,24(R)-dihydroxyvitamin D3 is catalyzed by 25-hydroxyvitamin D3-24-hydroxylase (CYP24A1): metabolism studies with human keratinocytes and rat recombinant CYP24A1.
    Astecker N; Bobrovnikova EA; Omdahl JL; Gennaro L; Vouros P; Schuster I; Uskokovic MR; Ishizuka S; Wang G; Reddy GS
    Arch Biochem Biophys; 2004 Nov; 431(2):261-70. PubMed ID: 15488475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of 20-epimer of 1alpha,25-dihydroxyvitamin D3 by CYP24: species-based difference between humans and rats.
    Kusudo T; Sakaki T; Abe D; Fujishima T; Kittaka A; Takayama H; Ohta M; Inouye K
    Biochem Biophys Res Commun; 2003 Oct; 309(4):885-92. PubMed ID: 13679056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of 2 alpha-propoxy-1 alpha,25-dihydroxyvitamin D3 and 2 alpha-(3-hydroxypropoxy)-1 alpha,25-dihydroxyvitamin D3 by human CYP27A1 and CYP24A1.
    Abe D; Sakaki T; Kusudo T; Kittaka A; Saito N; Suhara Y; Fujishima T; Takayama H; Hamamoto H; Kamakura M; Ohta M; Inouye K
    Drug Metab Dispos; 2005 Jun; 33(6):778-84. PubMed ID: 15764712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3 and 1alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D3: analogs of 1alpha,25-dihydroxyvitamin D3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway.
    Reddy GS; Rao DS; Siu-Caldera ML; Astecker N; Weiskopf A; Vouros P; Sasso GJ; Manchand PS; Uskokovic MR
    Arch Biochem Biophys; 2000 Nov; 383(2):197-205. PubMed ID: 11185554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the activation of 1alpha-hydroxyvitamin D2 by 25-hydroxyvitamin D-24-hydroxylase: delineation of pathways involving 1alpha,24-dihydroxyvitamin D2 and 1alpha,25-dihydroxyvitamin D2.
    Masuda S; Strugnell SA; Knutson JC; St-Arnaud R; Jones G
    Biochim Biophys Acta; 2006 Feb; 1761(2):221-34. PubMed ID: 16516540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of 26,26,26,27,27,27-F6-1alpha,25-dihydroxyvitamin D3 by CYP24: species-based difference between humans and rats.
    Sakaki T; Sawada N; Abe D; Komai K; Shiozawa S; Nonaka Y; Nakagawa K; Okano T; Ohta M; Inouye K
    Biochem Pharmacol; 2003 Jun; 65(12):1957-65. PubMed ID: 12787875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic analysis of human CYP24A1 metabolism of vitamin D via the C24-oxidation pathway.
    Tieu EW; Tang EK; Tuckey RC
    FEBS J; 2014 Jul; 281(14):3280-96. PubMed ID: 24893882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single A326G mutation converts human CYP24A1 from 25-OH-D3-24-hydroxylase into -23-hydroxylase, generating 1alpha,25-(OH)2D3-26,23-lactone.
    Prosser DE; Kaufmann M; O'Leary B; Byford V; Jones G
    Proc Natl Acad Sci U S A; 2007 Jul; 104(31):12673-8. PubMed ID: 17646648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antagonism between 2-methyl-1,25-dihydroxyvitamin D3 and 2-methyl-20-epi-1,25-dihydroxyvitamin D3 in non-genomic pathway-mediated biological responses induced by 1alpha,25-dihydroxyvitamin D3 assessed by NB4 cell differentiation.
    Miura D; Norman AW; Mizwicki MT; Fujishima T; Konno K; Kittaka A; Takayama H; Ishizuka S
    J Steroid Biochem Mol Biol; 2005 Apr; 94(5):469-79. PubMed ID: 15876412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioengineering anabolic vitamin D-25-hydroxylase activity into the human vitamin D catabolic enzyme, cytochrome P450 CYP24A1, by a V391L mutation.
    Kaufmann M; Prosser DE; Jones G
    J Biol Chem; 2011 Aug; 286(33):28729-28737. PubMed ID: 21697097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid homology modeling and mutational analysis of cytochrome P450C24A1 (CYP24A1) of the Vitamin D pathway: insights into substrate specificity and membrane bound structure-function.
    Annalora AJ; Bobrovnikov-Marjon E; Serda R; Pastuszyn A; Graham SE; Marcus CB; Omdahl JL
    Arch Biochem Biophys; 2007 Apr; 460(2):262-73. PubMed ID: 17207766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonistic action of novel 1alpha,25-dihydroxyvitamin D(3)-26, 23-lactone analogs on 25-hydroxyvitamin-D(3)-24-hydroxylase gene expression induced by 1alpha,25-dihydroxy-vitamin D(3) in human promyelocytic leukemia (HL-60) cells.
    Ishizuka S; Miura D; Eguchi H; Ozono K; Chokki M; Kamimura T; Norman AW
    Arch Biochem Biophys; 2000 Aug; 380(1):92-102. PubMed ID: 10900137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of the Redox Complex between Cytochrome P450 24A1 and Adrenodoxin Relies on Carbon-25 Hydroxylation of Vitamin-D Substrate.
    Kumar A; Estrada DF
    Drug Metab Dispos; 2019 Sep; 47(9):974-982. PubMed ID: 31289106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.